Abeona Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update Bluefield Daily Telegraph, 29 Mar 2023 Expects to submit BLA for EB-101 to FDA in late-2Q/early-3Q 2023 based on positive Phase 3 VIITAL™study results announced in 4Q…